Busulfan in patients with polycythemia vera or essential thrombocythemia refractory or intolerant to hydroxyurea

Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel

Ayalew Tefferi, Jüergen Thiele, Attilio Orazi et al. · Blood · 2007 · 858 citations · Full text

Medicine, Hematology, Internal Medicine +9

Philadelphia-Negative Classical Myeloproliferative Neoplasms: Critical Concepts and Management Recommendations From European LeukemiaNet

Tiziano Barbui, Giovanni Barosi, Gunnar Birgegård et al. · Journal of Clinical Oncology · 2011 · 834 citations · Full text

Medicine, Hematology, Oncology +17

Vascular and Neoplastic Risk in a Large Cohort of Patients With Polycythemia Vera

Roberto Marchioli, Guido Finazzi, Raffaele Landolfi et al. · Journal of Clinical Oncology · 2005 · 719 citations

Medicine, Hematology, Internal Medicine +12

Development and validation of an International Prognostic Score of thrombosis in World Health Organization–essential thrombocythemia (IPSET-thrombosis)

Tiziano Barbui, Guido Finazzi, Alessandra Carobbio et al. · Blood · 2012 · 589 citations · Full text

Medicine, Hematology, Internal Medicine +10

Acute leukemia in polycythemia vera: an analysis of 1638 patients enrolled in a prospective observational study

Guido Finazzi · Blood · 2004 · 428 citations · Full text

Medicine, Hematology, Oncology +11